Skip to main content
. 1998 Dec;180(23):6232–6241. doi: 10.1128/jb.180.23.6232-6241.1998

TABLE 1.

Bacterial strains and plasmids used in this study

Strain or plasmid Genotype or relevant characteristicsa Origin (reference)
S. aureus
 RN4220 Restriction negative, modification positive R. Novick 40
 8325-4 Wild-type strain cured of known prophages R. Novick 48
 PC6911 agrΔ::tetM Tcr Laboratory stock 12, 51
 PC2429 sarA+ sarA::km Kmr Eryr This study
 PC1839 sarA::km Kmr This study
 PC18391 sarA::km agrΔ::tetM Kmr Tcr This study
 PC322 hla+ hla::lacZ Eryr Laboratory stock 12
 PC3221 hla+ hla::lacZ sarA::km Eryr Kmr This study
 PC324 hla+ hla::lacZ agrΔ::tetM Eryr Tcr Laboratory stock 12
 PC3241 hla+ hla::lacZ sarA::km agrΔ::tetM Eryr Kmr Tcr This study
 PC203 spa+ spa::lacZ Eryr Laboratory stock 12
 PC2031 spa+ spa::lacZ sarA::km Eryr Kmr This study
 PC206 spa+ spa::lacZ agrΔ::tetM Eryr Tcr Laboratory stock 12
 PC2062 spa+ spa::lacZ sarA::km agrΔ::tetM Eryr Kmr Tcr This study
 PC1072 tst::lux Tcr Laboratory stock 12
 PC1091 tst::lux sarA::km Tcr Kmr This study
 S6 Enterotoxin-producing strain S. Khan 20
 PC1700 agrΔ::tetM in S6 Tcr This study
 PC1841 sarA::km in S6 Kmr This study
 PC1845 sarA::km agrΔ::tetM in S6 Tcr Kmr This study
E. coli DH5α φ80dlacZΔM15 recA1 endA1 gyrA96 thi-1 hsdR17 (rK mK+) supE44 relA1 deoR Δ(lacZYA-argF)U169 Promega Corp.
Plasmids
 pUBS1 E. coli cloning vector; Apr G. Murphy 25
 pAZ106 Promoterless, transcriptional lacZ fusion vector; Apr (E. coli) Eryr (S. aureus) A. Moir 38
 pDG783 1.5-kb kanamycin resistance cassette in pSB118; Apr P. Stragier 29
 pPC905 1.3-kb SalI-BamHI cut PCR fragment containing the complete sar operon in SalI-BamHI-cut pUBS1; Apr This study
 pH4 1.5-kb EcoRI fragment from pDG783 containing the kanamycin resistance cassette in EcoRI-cut pPC905; Apr This study
 pH4A5 3.3-kb PvuII fragment containing sarA::km in SmaI-cut pAZ106; Apr (E. coli) Eryr (S. aureus) This study
a

Abbreviations: Tcr, Kmr, Eryr, and Apr, resistance to tetracycline, kanamycin/neomycin, erythromycin/lincomycin, and ampicillin, respectively.